The Recall Desk
ModerateFDA (Devices)·Z-1774-2022·Announced 2022-09-28

Fungitell STAT IVD Assay affected by incorrect printed reconstitution instructions

Associates of Cape Cod is recalling Fungitell STAT IVD Assay kits due to incorrect printed information on clamshells regarding reconstitution and pretreatment volumes. Users should verify procedures against official documentation before use.

What this means for you

Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.

Our severity reasoning: This is an FDA Class II medical device recall involving incorrect printed information on product packaging. No illnesses or injuries have been reported. The hazard is potential for inaccurate test results if users follow the printed instructions, making this a labeling error without reported harm.

Plain-English summary

Associates of Cape Cod, Inc. is recalling Fungitell STAT IVD Assay for (1→3)-β-D-Glucan in Serum (Ref: FT007) in kit format. The recall affects 243 kits distributed worldwide, including in California and internationally to Austria, France, Germany, India, Ireland, Italy, Spain, and the United Kingdom.

The clamshells containing the Fungitell STAT Standard include incorrect printed information regarding the reconstitution and pretreatment volumes needed for the assay. Using incorrect volumes may result in inaccurate test results.

Users who have received affected lots (Lot #FK22008, Package Control #113041, Exp. Date 2023-11-21) should not rely solely on the printed instructions. Consult the correct procedural documentation from Associates of Cape Cod before performing the assay. Healthcare facilities and laboratories should verify their procedures immediately.

The recalled product

Product
Fungitell STAT- IVD Assay for (1 ¿ 3)-~-D-Glucan in Serum Ref: FT007
Manufacturer
Associates of Cape Cod, Inc.
Hazard
  • labeling-error
  • diagnostic-inaccuracy

Distribution

Distributed nationwide across the United States.